Jump to:

Philip Morris

Merrell Dow Pharmaceutical Meeting - 820713

Date: 21 Jul 1982
Length: 1 page
2023799798
Jump To Images
snapshot_pm 2023799798

Fields

Author
Latshaw, R.D.
Type
MEMO, MEMORANDUM
MINU, MINUTES
Area
PM USA/CARLSTADT
Copied
Harris, W.B.
Hedberg, F.A.
Kay, A.J., J.R.
Morgan, L.W.
Request
Stmn/R1-004
Stmn/R1-071
Master ID
2023799789/9807

Related Documents:
Document File
2023799679/2023799822/Operations 940000 - 860000
Named Organization
Dow Chemical
Merrell Dow Pharmaceutical
Smoking Cessation Newsletter
Site
N308
Litigation
Stmn/Produced
Stmn/Trial Exhibit P-11695
Txag/Trial Exhibit P-15683
Stmn/Selected
Characteristic
ATCH, ATTACHMENTS MISSING
ILLE, ILLEGIBLE
MARG, MARGINALIA
Named Person
Bujold, J.J.
Monroe, K.R., J.R.
Ihrig, R.S.
Kay, A.J., J.R.
Latshaw, R.D.
Morgan, L.W.
Recipient (Organization)
PM, Philip Morris
Attendee (Organization)
Merrell Dow Pharmaceutical
Dow Chemical
Author (Organization)
PM, Philip Morris
Date Loaded
27 Feb 1998
UCSF Legacy ID
itu93e00

Document Images

Text Control

Highlight Text:

OCR Text Alignment:

Image Control

Image Rotation:

Image Size:

Page 1: itu93e00
PHILIP MORRIS U. S. A. INTER-OFFiCE CORRESPONDENCE RlCNMOND, YIRGINIA To: From: . Subject: . FILE R. D. Latshaw Date: MERRELL DOW PHARMACEUTICAL MEETING - JULY 13, 1982 IN ATTENDANCE: July 21, 1982 DOW - K. R. Monroe, Jr. - Vice President Marketing, Merrell Dow - R. S. Ihrig - General Sales Manager, Dow Chemical - J. J. Bujold - Corporate Account Manager, Dow Chemical PHILIP MORRIS - A. J. Kay, Jr. - L. W. Morgan - R. D. Latshaw I Joe Bujold requested this meeting so that Merrell Dow could present their position on the smoking and health issue. The following major points were covered: 1. Dow Chemical and Merrell Dow are not anti smoking. They are not inten- tionally engaged in an assault on the cigarette industry. 2. Merrell's Nicorette "chewing gum" is a prescription drug sold through doctors to those patients who must quit smoking for health reasons. It is not a product aimed at the general smoking public, as evidenced by its "lousy" taste and reportedly high cost. 3. Ken Monroe was unhappy with the inflammatory anti-cigarette tone of - the first edition of The Smoking Cessation Newsletter. Apparently, newsletter was released before Monroe had taken over his new job. The second edition (copy attached) is on hold and Monroe is contem- plating modification of this edition as well as termination of this publication. We encouraged him to cease further publication. the 4. We emphasized our dissatisfaction was not with Do.w's manufacturing and distributing a pharmaceutical intended to help smokers who must quit for medical reasons. Rather, we are displeased with Dow's circulation of anti-smoking propaganda, particularly literature which has little or no scientific basis. -- 5. Dow reported the "press" was investigating a story that the Tobacco Industry was pressuring Dow to drop Nicorette. Attachment cc: F. A. Hedberg W. B. Harris A. J. Kay, Jr. L. W. Morgan /t k 2Q23'799'798

Text Control

Highlight Text:

OCR Text Alignment:

Image Control

Image Rotation:

Image Size: